185 related articles for article (PubMed ID: 37726845)
1. Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating human plasma proteome with genome.
Sun J; Zhao J; Jiang F; Wang L; Xiao Q; Han F; Chen J; Yuan S; Wei J; Larsson SC; Zhang H; Dunlop MG; Farrington SM; Ding K; Theodoratou E; Li X
Genome Med; 2023 Sep; 15(1):75. PubMed ID: 37726845
[TBL] [Abstract][Full Text] [Related]
2. Exploring the cross-cancer effect of circulating proteins and discovering potential intervention targets for 13 site-specific cancers.
Sun J; Luo J; Jiang F; Zhao J; Zhou S; Wang L; Zhang D; Ding Y; Li X
J Natl Cancer Inst; 2024 Apr; 116(4):565-573. PubMed ID: 38039160
[TBL] [Abstract][Full Text] [Related]
3. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes.
Yang C; Fagan AM; Perrin RJ; Rhinn H; Harari O; Cruchaga C
Genome Med; 2022 Dec; 14(1):140. PubMed ID: 36510323
[TBL] [Abstract][Full Text] [Related]
4. Systematic investigation of genetically determined plasma and urinary metabolites to discover potential interventional targets for colorectal cancer.
Sun J; Zhao J; Zhou S; Li X; Li T; Wang L; Yuan S; Chen D; Law PJ; Larsson SC; Farrington SM; Houlston RS; Dunlop MG; Theodoratou E; Li X
J Natl Cancer Inst; 2024 Apr; ():. PubMed ID: 38648753
[TBL] [Abstract][Full Text] [Related]
5. Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.
Zhang L; Xiong Y; Zhang J; Feng Y; Xu A
J Transl Med; 2024 Apr; 22(1):330. PubMed ID: 38576019
[TBL] [Abstract][Full Text] [Related]
6. Novel Drug Targets for Ischemic Stroke Identified Through Mendelian Randomization Analysis of the Blood Proteome.
Chong M; Sjaarda J; Pigeyre M; Mohammadi-Shemirani P; Lali R; Shoamanesh A; Gerstein HC; Paré G
Circulation; 2019 Sep; 140(10):819-830. PubMed ID: 31208196
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses.
Chen J; Xu F; Ruan X; Sun J; Zhang Y; Zhang H; Zhao J; Zheng J; Larsson SC; Wang X; Li X; Yuan S
EBioMedicine; 2023 Mar; 89():104494. PubMed ID: 36857861
[TBL] [Abstract][Full Text] [Related]
8. Genome-Wide Association and Transcriptome-Wide Association Studies Identify Novel Susceptibility Genes Contributing to Colorectal Cancer.
Yin R; Song B; Wang J; Shao C; Xu Y; Jiang H
J Immunol Res; 2022; 2022():5794055. PubMed ID: 35812248
[TBL] [Abstract][Full Text] [Related]
9. Proteome-wide analysis reveals potential therapeutic targets for Colorectal cancer: a two-sample mendelian randomization study.
Cai YX; Wu YQ; Liu J; Pan H; Deng W; Sun W; Xie C; Huang XF
BMC Cancer; 2023 Dec; 23(1):1188. PubMed ID: 38049731
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Targets for Diabetic Kidney Disease: Proteome-Wide Mendelian Randomization and Colocalization Analyses.
Zhang W; Ma L; Zhou Q; Gu T; Zhang X; Xing H
Diabetes; 2024 Apr; 73(4):618-627. PubMed ID: 38211557
[TBL] [Abstract][Full Text] [Related]
11. Assessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study.
Morales Berstein F; McCartney DL; Lu AT; Tsilidis KK; Bouras E; Haycock P; Burrows K; Phipps AI; Buchanan DD; Cheng I; ; Martin RM; Davey Smith G; Relton CL; Horvath S; Marioni RE; Richardson TG; Richmond RC
Elife; 2022 Mar; 11():. PubMed ID: 35346416
[TBL] [Abstract][Full Text] [Related]
12. Integrating plasma proteomes with genome-wide association data for causal protein identification in multiple myeloma.
Wang Q; Shi Q; Wang Z; Lu J; Hou J
BMC Med; 2023 Sep; 21(1):377. PubMed ID: 37775746
[TBL] [Abstract][Full Text] [Related]
13. Clinically relevant plasma proteome for adiposity depots: evidence from systematic mendelian randomization and colocalization analyses.
Cao M; Cui B
Cardiovasc Diabetol; 2024 Apr; 23(1):126. PubMed ID: 38614964
[TBL] [Abstract][Full Text] [Related]
14. Novel Causal Plasma Proteins for Hypothyroidism: A Large-scale Plasma Proteome Mendelian Randomization Analysis.
Yang H; Chen L; Liu Y
J Clin Endocrinol Metab; 2023 Jan; 108(2):433-442. PubMed ID: 36190832
[TBL] [Abstract][Full Text] [Related]
15. Identification of host gene-microbiome associations in colorectal cancer patients using mendelian randomization.
Xiang Y; Zhang C; Wang J; Cheng Y; Wang L; Tong Y; Yan D
J Transl Med; 2023 Aug; 21(1):535. PubMed ID: 37563724
[TBL] [Abstract][Full Text] [Related]
16. Proteome-wide Mendelian randomization highlights AIF1 and HLA-DQA2 as targets for primary sclerosing cholangitis.
Chen L; Zhao Y; Li M; Lv G
Hepatol Int; 2024 Apr; 18(2):517-528. PubMed ID: 37950809
[TBL] [Abstract][Full Text] [Related]
17. Genetically Determined Chronic Low-Grade Inflammation and Hundreds of Health Outcomes in the UK Biobank and the FinnGen Population: A Phenome-Wide Mendelian Randomization Study.
Si S; Li J; Tewara MA; Xue F
Front Immunol; 2021; 12():720876. PubMed ID: 34386016
[TBL] [Abstract][Full Text] [Related]
18. Proteome-Wide Mendelian Randomization and Colocalization Analysis Identify Therapeutic Targets for Knee and Hip Osteoarthritis.
Zou M; Shao Z
Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540773
[TBL] [Abstract][Full Text] [Related]
19. Proteome-wide mendelian randomization study implicates therapeutic targets in common cancers.
Ren F; Jin Q; Liu T; Ren X; Zhan Y
J Transl Med; 2023 Sep; 21(1):646. PubMed ID: 37735436
[TBL] [Abstract][Full Text] [Related]
20. A novel multi-ancestry proteome-wide Mendelian randomization study implicates extracellular proteins, tubular cells, and fibroblasts in estimated glomerular filtration rate regulation.
Lanktree MB; Perrot N; Smyth A; Chong M; Narula S; Shanmuganathan M; Kroezen Z; Britz-Mckibbin P; Berger M; Krepinsky JC; Pigeyre M; Yusuf S; Paré G
Kidney Int; 2023 Dec; 104(6):1170-1184. PubMed ID: 37774922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
